| Market design to accelerate COVID-19 vaccine supply JC Castillo, A Ahuja, S Athey, A Baker, E Budish, T Chipty, R Glennerster, ... Science 371 (6534), 1107-1109, 2021 | 174 | 2021 |
| Preparing for a pandemic: Accelerating vaccine availability A Ahuja, S Athey, A Baker, E Budish, JC Castillo, R Glennerster, ... AEA Papers and Proceedings 111, 331-35, 2021 | 75 | 2021 |
| End COVID-19 in low-and middle-income countries AM Mobarak, E Miguel, J Abaluck, A Ahuja, M Alsan, A Banerjee, E Breza, ... Science 375 (6585), 1105-1110, 2022 | 63 | 2022 |
| Testing fractional doses of COVID-19 vaccines W Więcek, A Ahuja, E Chaudhuri, M Kremer, AS Gomes, CM Snyder, ... Proceedings of the National Academy of Sciences 119 (8), 2022 | 46 | 2022 |
| Nivolumab versus cabozantinib: comparing overall survival in metastatic renal cell carcinoma W Wiecek, H Karcher PLoS One 11 (6), e0155389, 2016 | 37 | 2016 |
| Exploring Risks of Human Challenge Trials For COVID‐19 D Manheim, W Wiȩcek, V Schmit, J Morrison, ... Risk Analysis 41 (5), 710-720, 2021 | 28 | 2021 |
| Human variability in polymorphic CYP2D6 metabolism: Implications for the risk assessment of chemicals in food and emerging designer drugs K Darney, LS Lautz, C Béchaux, W Wiecek, E Testai, B Amzal, J Dorne Environment International 156, 106760, 2021 | 25 | 2021 |
| A Systematic Review of Human Challenge Trials, Designs, and Safety J Adams-Phipps, D Toomey, W Więcek, V Schmit, J Wilkinson, K Scholl, ... Clinical Infectious Diseases 76 (4), 609-619, 2023 | 24 | 2023 |
| Water Treatment And Child Mortality: A Meta-Analysis And Cost-effectiveness Analysis M Kremer, SP Luby, R Maertens, B Tan, W Więcek National Bureau of Economic Research, 2023 | 19 | 2023 |
| The Yin–Yang of CYP3A4: a Bayesian meta-analysis to quantify inhibition and induction of CYP3A4 metabolism in humans and refine uncertainty factors for mixture risk assessment N Quignot, W Wiecek, B Amzal, JL Dorne Archives of toxicology 93 (1), 107-119, 2019 | 18 | 2019 |
| Cabozantinib versus standard-of-care comparators in the treatment of advanced/metastatic renal cell carcinoma in treatment-naive patients: a systematic review and network meta … E Schmidt, J Lister, M Neumann, W Wiecek, S Fu, AL Vataire, J Sostar, ... Targeted Oncology 13, 205-216, 2018 | 15 | 2018 |
| A generic Bayesian hierarchical model for the meta-analysis of human population variability in kinetics and its applications in chemical risk assessment W Wiecek, JL Dorne, N Quignot, C Bechaux, B Amzal Computational Toxicology 12, 100106, 2019 | 13 | 2019 |
| Impact of increased influenza vaccination in 2–3-year-old children on disease burden within the general population: A Bayesian model-based approach S Rajaram, W Wiecek, R Lawson, BT Blak, Y Zhao, J Hackett, R Brody, ... PLoS One 12 (12), e0186739, 2017 | 13 | 2017 |
| Could Vaccine Dose Stretching Reduce COVID-19 Deaths? W Więcek, A Ahuja, M Kremer, AS Gomes, C Snyder, A Tabarrok, BJ Tan National Bureau of Economic Research, 2021 | 8 | 2021 |
| Inter-phenotypic differences in CYP2C9 and CYP2C19 metabolism: Bayesian meta-regression of human population variability in kinetics and application in chemical risk assessment N Quignot, W Więcek, L Lautz, JL Dorne, B Amzal Toxicology Letters 337, 111-120, 2021 | 6 | 2021 |
| “TKPlate”: A web-based platform for toxicokinetic modelling in food safety N Quignot, W Wiecek, B Amzal, JLCM Dorne Toxicology Letters 295, S248, 2018 | 6 | 2018 |
| Mapping interindividual variability of toxicodynamics using high-throughput transcriptomics and primary human hepatocytes from fifty donors M Niemeijer, W Więcek, S Fu, S Huppelschoten, P Bouwman, A Baze, ... Environmental Health Perspectives 132 (3), 037005, 2024 | 5 | 2024 |
| Meta-analysis and public policy: reconciling the evidence on deworming K Croke, J Hamory, E Hsu, M Kremer, R Maertens, E Miguel, W Więcek Proceedings of the National Academy of Sciences 121 (25), e2308733121, 2024 | 4 | 2024 |
| Clinical trials for accelerating pandemic vaccines W Więcek Oxford Review of Economic Policy 38 (4), 797-817, 2022 | 4 | 2022 |
| Transcriptomic mapping of the inter-individual variability of cellular stress response activation in primary human hepatocytes M Niemeijer, W Wiecek, S Huppelschoten, P Bouwman, A Baze, ... bioRxiv, 2021.08. 26.457742, 2021 | 4 | 2021 |
